Greystone Associates Report Analyzes Clinical, Regulatory and Therapeutic Factors Driving Growth of Immune Factor Drugs

Greystone Associates Report Analyzes Clinical, Regulatory and Therapeutic Factors Driving Growth of Powerful New Drugs Based on the Human Immune Response

A research team at Weill Cornell Medical College in New York City has identified two genes that may be crucial to the production of an immune system cytokine called interleukin-10 (IL-10).

In an upcoming Genes & Development paper, Dr. Christopher Counter and colleagues at the Duke University Medical Center have identified IL6 as a new target in the battle against Ras-induced cancers.